Literature DB >> 16154780

Chronic inflammation does not appear to modify the homozygous hereditary hemochromatosis phenotype.

Ernest Beutler1, Jill Waalen, Terri Gelbart.   

Abstract

The mechanism of excessive iron storage in patients with hereditary hemochromatosis caused by mutations of the HFE gene seems to be a failure to up-regulate hepcidin in the face of increased body iron. Since the cytokines IL-1 and IL-6 stimulate hepcidin transcription in the absence of HFE, chronic inflammatory states might counteract the effect of HFE mutations. We measured the pre-phlebotomy plasma levels of C reactive protein (CRP) and of interleukin 6 (IL-6) in homozygotes for the C282Y mutation of HFE. There was no difference in these levels in subjects with high iron stores than in those with low iron stores, suggesting that the phenotypic differences between such homozygotes is not appreciably affected by ongoing chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154780     DOI: 10.1016/j.bcmd.2005.08.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  4 in total

1.  Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.

Authors:  Marcel van Deuren; Joyce J C Kroot; Dorine W Swinkels
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

2.  HFE gene mutations increase the risk of coronary heart disease in women.

Authors:  M Carolina Pardo Silva; Omer T Njajou; Behrooz Z Alizadeh; Albert Hofman; Jacqueline C M Witteman; Cornelia M van Duijn; A Cecile J W Janssens
Journal:  Eur J Epidemiol       Date:  2010-07-18       Impact factor: 8.082

Review 3.  Iron storage disease: facts, fiction and progress.

Authors:  Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2007-05-31       Impact factor: 3.039

Review 4.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.